PFS
CLRB icon

Prospera Financial Services’s Cellectar Biosciences CLRB Stock Holding History

Prospera Financial Services’s Portfolio CLRB Stock Details CLRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-18
Closed -$2K – 974
2022
Q2 		$2K Sell
18
-28
-61% -$4K ﹤0.01% 1540
2022
Q1 		$9K Hold
46
– – ﹤0.01% 2063
2021
Q4 		$9K Sell
46
-3
-6% -$722 ﹤0.01% 865
2021
Q3 		$14K Hold
49
– – ﹤0.01% 791
2021
Q2 		$17K Hold
49
– – ﹤0.01% 789
2021
Q1 		$24K Buy
+49
New +$29.1K ﹤0.01% 742
2020
Q4 		– Sell
-3
Closed -$1K – 825
2020
Q3 		$1K Buy
+3
New +$1.19K ﹤0.01% 1525

Other funds holding CLRB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $127M AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Prospera Financial Services's CLRB Position: Q3 2022 in Review

Prospera Financial Services sold out of Cellectar Biosciences (CLRB) in Q3 2022, closing a stake of 18 shares — an estimated $2K sold.

Prospera Financial Services first reported a position in CLRB in Q3 2020 and held it in 7 quarters. The position peaked at $24K in Q1 2021. 20 funds tracked by Wall St. Rank hold CLRB as of Q3 2022.

  • Prospera Financial Services reported no remaining Cellectar Biosciences position as of Q3 2022 after selling out during the quarter.
  • Prospera Financial Services sold 18 Cellectar Biosciences shares in Q3 2022, an estimated $2K.
  • Prospera Financial Services first reported a position in Cellectar Biosciences in Q3 2020 and held it in 7 quarters.
  • Prospera Financial Services's Cellectar Biosciences position peaked at $24K in Q1 2021.
  • 20 funds tracked by Wall St. Rank held Cellectar Biosciences as of Q3 2022.

Based on Prospera Financial Services's 13F filing for Q3 2022, filed 27 Oct 2022.